GOSS: Gossamer Bio, Inc. Stock

by  •  • Comments Off on GOSS: Gossamer Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 174.19
Enterprise Value ($M) 343.02
Book Value ($M) 54.14
Book Value / Share 0.24
Price / Book 3.22
NCAV ($M) 47.52
NCAV / Share 0.21
Price / NCAV 3.67

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.68

Liquidity (mrq)
Quick Ratio 6.74
Current Ratio 6.74

Balance Sheet (mrq) ($M)
Current Assets 344.27
Assets 350.88
Liabilities 296.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
6 days ago 13G/A Fmr Llc 3.51 -35.29
6 days ago 13G/A Invus Global Management, LLC 6.30 -0.19
02-14 13G/A Hillhouse Capital Management, Ltd. 2.20
02-13 13G/A Vanguard Group Inc 5.16 46.18
02-09 13G/A ARCH Venture Fund IX, L.P.
01-11 13G/A Millennium Management Llc 1.90 -12.07
01-11 13G Artal International S.C.A. 5.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-07 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 179,415 605,743 29.62
2024-11-14 514,785 2,216,793 23.22
2024-11-13 233,150 1,014,007 22.99
2024-11-12 410,999 1,224,424 33.57

(click for more detail)

Similar Companies
GERN – Geron Corporation GILD – Gilead Sciences, Inc.
GLUE – Monte Rosa Therapeutics, Inc. HALO – Halozyme Therapeutics, Inc.
HLVX – HilleVax, Inc.


Financial data and stock pages provided by
Fintel.io